IL6 and congenital rubella syndrome: Metoprolol works by inhibiting the protein translation extension of IL-6 in monocytes and macrophages, and first illuminated the possibility of protein translation as a therapeutic target for controlling CRS and the molecular mechanism by which metoprolol inhibits IL-6 translation.